Bloomage Biotechnology
Bloomage Biotechnology is a China-based bioscience company leveraging CDP disclosure to translate environmental data into structured management capability.
In 2025, Bioscience company Bloomage Biotechnology achieved a CDP A score for water security. The company has built a centralized environmental data system covering energy, water, emissions and waste across operations—creating a robust foundation for data-driven management and decision-making.
Through CDP disclosure, Bloomage Biotechnology has strengthened its management approach and delivered measurable environmental outcomes.
How Bloomage Biotechnology is taking action
Using CDP as an integrated environmental platform to enable consistent data collection, consolidation and management across departments.
Risk identification and target-setting are embedded into decision-making, systematically addressing climate and resource-related risks.
These priorities are translated into action through renewable energy deployment, efficiency improvements and green initiatives across operations.
What this has delivered
Completed its first full value chain greenhouse gas accounting and verification in 2024, marking a key milestone in expanding emissions visibility.
The biosynthesis-based production pathway for hyaluronic acid reduces carbon emissions intensity by 35–65% compared with conventional extraction methods.
Approximately 28,224.33 tonnes of CO₂e emissions reduced in 2025.
By identifying gaps in value chain emissions data, the company has strengthened data quality, traceability and cross-functional collaboration—laying the groundwork for continuous improvement.
Bloomage Biotechnology’s experience shows how CDP disclosure can move beyond reporting—supporting stronger risk management, operational efficiency and long-term resilience.
Explore more case studies
Discover how organizations are benefiting by disclosing through CDP. Browse our full selection of disclosure-related case studies.
